Example: marketing

Development safety update report ich

Found 8 free book(s)
ICH guideline E2F on development safety update …

ICH guideline E2F on development safety update

www.ema.europa.eu

The Development Safety Update Report (DSUR) proposed in this guideline is intended to be a common standard for periodic reporting on drugs under development (including marketed drugs that are under

  Development, Guidelines, Report, Update, Safety, Development safety update report, Ich guideline e2f on development safety update

Overview of ICH E2F – Development …

Overview of ICH E2F – Development

www.ich.org

Overview of ICH E2F – Development SafetyDevelopment Safety Update Report (DSUR) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use

  International, Development, Report, Update, Safety, Conference, International conference on harmonisation, Harmonisation, Safetydevelopment, Ich e2f development safetydevelopment safety update report

Drug Development 1.2 Procedures for Clinical Trials

Drug Development 1.2 Procedures for Clinical Trials

www.jpma.or.jp

37 Basic standards for periodically reporting safety information during the development phase, common to all drugs, etc., are available in “Development Safety Update

  Development, Update, Safety, Clinical, Procedures, Trail, Procedures for clinical trials, Development safety update

DEVELOPMENT SAFETY UPDATE REPORT - ICH

DEVELOPMENT SAFETY UPDATE REPORT - ICH

www.ich.org

The Development Safety Update Report (DSUR) proposed in this guideline is intended to be a common standard for periodic reporting on drugs under development (including

  Development, Report, Update, Safety, Development safety update report, Development safety update report ich

STABILITY TESTING OF ACTIVE PHARMACEUTICAL …

STABILITY TESTING OF ACTIVE PHARMACEUTICAL

www.who.int

Working document QAS/17.694 page 2 30 SCHEDULE FOR THE PROPOSED ADOPTION PROCESS OF DOCUMENT 31 QAS/17.694: 32 STABILITY TESTING OF ACTIVE PHARMACEUTICAL INGREDIENTS 33 AND FINISHED PHARMACEUTICAL PRODUCTS 34 Development of the proposal to update the guideline for stability testing of active pharmaceutical ingredients and

  Development, Product, Pharmaceutical, Update, Ingredients, Pharmaceutical ingredients and, Finished pharmaceutical products, Finished

Medicines Control Council

Medicines Control Council

www.mccza.com

Registration of Medicines Reporting of Adverse Drug Reactions 2.11_ADR_reporting_May03_v1_2.doc December 2012 Page 1 of 18 MEDICINES CONTROL COUNCIL REPORTING ADVERSE DRUG REACTIONS

  Control, Medicine, Council, Medicines control council

Post-marketing Surveillance of Drugs - JPMA

Post-marketing Surveillance of Drugs - JPMA

www.jpma.or.jp

73 CHAPTER 4 Post-marketing Surveillance of Drugs . Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and

  Drug, Surveillance, Safety, Marketing, Post, Post marketing surveillance of drugs

DEVELOPMENT OF PAEDIATRIC MEDICINES: …

DEVELOPMENT OF PAEDIATRIC MEDICINES:

www.who.int

working document qas/08.257/rev.3 august 2011 restricted development of paediatric medicines: points to consider in pharmaceutical development

  Development, Pharmaceutical, Points, Medicine, Paediatric, Consider, Development of paediatric medicines, Points to consider in pharmaceutical development

Similar queries